Newsmeme!
Discover News you didn't know existed
Kids today may not be familiar with ''Mam'' Jintara Sukapat. They may only know her as ''that lady who plays the Mum in lakorn''. But to those growing up in the 1980s and 90s, she's Thailand's sweetheart.
06 September 2008 AL AIN - A campaign titled "Together Against Diabetes" is currently under way at Al Ain Hospital to raise awareness of the disease and the risk factors among the people. The campaign will run until September 27.
Washington, Sept 5 : A new study has found that obesity and Type 2 Diabetes Mellitus (T2DM) can contribute to mild neurodegeneration with features common with Alzheimer's disease (AD).
It is a wonderful job the man is doing to get people relieved, breathing hope into their lives. He has succeeded in many operations of neurosurgery.
Onychomycosis is a general term referring to several fungal infections of the nails. The disease is caused by fungi which may be grouped as dermatophytes, nondermatophytes, yeasts or a mixture.
Does dark matter cause ACL injuries? I see two types of dark matter on our radar. One is quite exciting, at least to this former astronomy major, and one is potentially catastrophic.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc. (MRF).
Obesity and Type 2 Diabetes Mellitus can contribute to mild neurodegeneration with features common with Alzheimer's disease -- the first study to show that obesity can cause neurodegeneration.
WORCESTER, Mass., Sept. 5, 2008 -- Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will present study results at the 44th Annual Meeting of the European Association for the Study of Diabetes to be held in Rome, Italy, September 6 - 11, 2008 .
Corcept Therapeutics announced that Eli Lilly and Company (Lilly) has agreed to fund studies to test the effectiveness of Corcept's selective GRII receptor antagonist, CORT 108297, in rat models of olanzapine induced weight gain.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |